Outset Medical, Inc. (NASDAQ:OM) CEO Leslie Trigg Sells 33,227 Shares

Outset Medical, Inc. (NASDAQ:OM) CEO Leslie Trigg sold 33,227 shares of Outset Medical stock in a transaction dated Monday, January 13th. The stock was sold at an average price of $0.81, for a total value of $26,913.87. Following the sale, the chief executive officer now directly owns 861,397 shares of the company’s stock, valued at approximately $697,731.57. This trade represents a 3.71 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink.

Leslie Trigg also recently made the following trade(s):

• On Tuesday, January 7th, Leslie Trigg sold 10,227 shares of Outset Medical stock. The stock was sold at an average price of $1.29, for a total transaction of $13,192.83.
• On Friday, November 15th, Leslie Trigg sold 5,645 shares of Outset Medical stock. The stock was sold at an average price of $0.80, for a total transaction of $4,516.00.

Outset Medical Stock Performance

NASDAQ:OM opened at $0.81 on Tuesday. The firm’s fifty day simple moving average is $1.01 and its 200 day simple moving average is $1.41. The stock has a market cap of $42.44 million, a P/E ratio of -0.29 and a beta of 2.05. The company has a quick ratio of 5.04, a current ratio of 6.49 and a debt-to-equity ratio of 4.12. Outset Medical, Inc. has a twelve month low of $0.44 and a twelve month high of $5.22.

Analysts Set New Price Targets

Separately, Royal Bank of Canada reaffirmed a “sector perform” rating and set a $3.00 price objective on shares of Outset Medical in a research note on Tuesday, January 7th.

Hedge Funds Weigh In On Outset Medical

Several institutional investors and hedge funds have recently added to or reduced their stakes in the company. National Bank of Canada FI grew its stake in shares of Outset Medical by 79.2% in the 3rd quarter. National Bank of Canada FI now owns 52,407 shares of the company’s stock worth $35,000 after buying an additional 23,164 shares during the last quarter. Huntington National Bank boosted its holdings in Outset Medical by 46.2% in the third quarter. Huntington National Bank now owns 63,306 shares of the company’s stock worth $43,000 after acquiring an additional 20,000 shares in the last quarter. Vanguard Personalized Indexing Management LLC purchased a new stake in shares of Outset Medical in the second quarter worth $49,000. Point72 Asia Singapore Pte. Ltd. purchased a new stake in shares of Outset Medical in the second quarter worth $259,000. Finally, Squarepoint Ops LLC increased its holdings in shares of Outset Medical by 74.1% during the second quarter. Squarepoint Ops LLC now owns 80,300 shares of the company’s stock valued at $309,000 after acquiring an additional 34,187 shares in the last quarter.

About Outset Medical

Outset Medical, Inc, a medical technology company, engages in the development of a hemodialysis system for hemodialysis in the United States. The company offers Tablo Hemodialysis System, a compact console with integrated water purification, on-demand dialysate production, and software and connectivity capabilities for dialysis care in acute and home settings; and manufactures, supports, and distributes for Tablo console, Tablo cartridge, and other consumables.